US Stock MarketDetailed Quotes

PHIO Phio Pharmaceuticals

Watchlist
  • 0.7869
  • +0.0545+7.44%
Close May 17 16:00 ET
  • 0.7506
  • -0.0363-4.61%
Post 18:28 ET
3.61MMarket Cap-312P/E (TTM)

Phio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-38.67%2.21M
-6.67%10.7M
-35.05%1.77M
-22.26%2.78M
1.03%2.55M
36.44%3.6M
-15.17%11.46M
-20.87%2.73M
-4.49%3.57M
-6.07%2.52M
Selling and administrative expenses
-27.72%1.06M
-1.89%4.37M
-31.36%766K
-8.94%968K
-4.35%1.16M
39.28%1.47M
-3.78%4.45M
-8.90%1.12M
-0.28%1.06M
8.18%1.22M
-General and administrative expense
-27.72%1.06M
-1.89%4.37M
-31.36%766K
-8.94%968K
-4.35%1.16M
39.28%1.47M
-3.78%4.45M
-8.90%1.12M
-0.28%1.06M
8.18%1.22M
Research and development costs
-46.20%1.15M
-9.70%6.33M
-37.61%1.01M
-27.91%1.81M
6.06%1.38M
34.55%2.13M
-21.09%7.01M
-27.46%1.61M
-6.17%2.51M
-16.36%1.3M
Operating profit
38.67%-2.21M
6.67%-10.7M
35.05%-1.77M
22.26%-2.78M
-1.03%-2.55M
-36.44%-3.6M
15.17%-11.46M
20.87%-2.73M
4.49%-3.57M
6.07%-2.52M
Net non-operating interest income expense
Other net income (expense)
55K
-611.11%-128K
-12,100.00%-122K
20.00%-4K
80.00%-2K
-108.04%-18K
0.00%-1K
-66.67%-5K
-233.33%-10K
Special income (charges)
----
---126K
----
----
----
----
--0
----
----
----
-Less:Impairment of capital assets
----
--126K
----
----
----
----
--0
----
----
----
Other non- operating income (expenses)
--55K
88.89%-2K
500.00%4K
20.00%-4K
80.00%-2K
----
-108.04%-18K
0.00%-1K
-66.67%-5K
-233.33%-10K
Income before tax
40.20%-2.15M
5.70%-10.83M
30.61%-1.9M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.6M
13.60%-11.48M
20.86%-2.73M
4.44%-3.58M
5.81%-2.53M
Income tax
Net income
40.20%-2.15M
5.70%-10.83M
30.61%-1.9M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.6M
13.60%-11.48M
20.86%-2.73M
4.44%-3.58M
5.81%-2.53M
Net income continuous Operations
40.20%-2.15M
5.70%-10.83M
30.61%-1.9M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.6M
13.60%-11.48M
20.86%-2.73M
4.44%-3.58M
5.81%-2.53M
Minority interest income
Net income attributable to the parent company
40.20%-2.15M
5.70%-10.83M
30.61%-1.9M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.6M
13.60%-11.48M
20.86%-2.73M
4.44%-3.58M
5.81%-2.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
40.20%-2.15M
5.70%-10.83M
30.61%-1.9M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.6M
13.60%-11.48M
20.86%-2.73M
4.44%-3.58M
5.81%-2.53M
Basic earnings per share
85.08%-0.47
48.51%-5.2
92.92%-0.17
63.69%-1.14
33.78%-1.47
-34.62%-3.15
18.71%-10.1
21.70%-2.4
6.55%-3.14
7.50%-2.22
Diluted earnings per share
85.08%-0.47
48.51%-5.2
92.92%-0.17
63.69%-1.14
33.78%-1.47
-34.62%-3.15
18.71%-10.1
21.70%-2.4
6.55%-3.14
7.50%-2.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -38.67%2.21M-6.67%10.7M-35.05%1.77M-22.26%2.78M1.03%2.55M36.44%3.6M-15.17%11.46M-20.87%2.73M-4.49%3.57M-6.07%2.52M
Selling and administrative expenses -27.72%1.06M-1.89%4.37M-31.36%766K-8.94%968K-4.35%1.16M39.28%1.47M-3.78%4.45M-8.90%1.12M-0.28%1.06M8.18%1.22M
-General and administrative expense -27.72%1.06M-1.89%4.37M-31.36%766K-8.94%968K-4.35%1.16M39.28%1.47M-3.78%4.45M-8.90%1.12M-0.28%1.06M8.18%1.22M
Research and development costs -46.20%1.15M-9.70%6.33M-37.61%1.01M-27.91%1.81M6.06%1.38M34.55%2.13M-21.09%7.01M-27.46%1.61M-6.17%2.51M-16.36%1.3M
Operating profit 38.67%-2.21M6.67%-10.7M35.05%-1.77M22.26%-2.78M-1.03%-2.55M-36.44%-3.6M15.17%-11.46M20.87%-2.73M4.49%-3.57M6.07%-2.52M
Net non-operating interest income expense
Other net income (expense) 55K-611.11%-128K-12,100.00%-122K20.00%-4K80.00%-2K-108.04%-18K0.00%-1K-66.67%-5K-233.33%-10K
Special income (charges) -------126K------------------0------------
-Less:Impairment of capital assets ------126K------------------0------------
Other non- operating income (expenses) --55K88.89%-2K500.00%4K20.00%-4K80.00%-2K-----108.04%-18K0.00%-1K-66.67%-5K-233.33%-10K
Income before tax 40.20%-2.15M5.70%-10.83M30.61%-1.9M22.26%-2.78M-0.71%-2.55M-36.34%-3.6M13.60%-11.48M20.86%-2.73M4.44%-3.58M5.81%-2.53M
Income tax
Net income 40.20%-2.15M5.70%-10.83M30.61%-1.9M22.26%-2.78M-0.71%-2.55M-36.34%-3.6M13.60%-11.48M20.86%-2.73M4.44%-3.58M5.81%-2.53M
Net income continuous Operations 40.20%-2.15M5.70%-10.83M30.61%-1.9M22.26%-2.78M-0.71%-2.55M-36.34%-3.6M13.60%-11.48M20.86%-2.73M4.44%-3.58M5.81%-2.53M
Minority interest income
Net income attributable to the parent company 40.20%-2.15M5.70%-10.83M30.61%-1.9M22.26%-2.78M-0.71%-2.55M-36.34%-3.6M13.60%-11.48M20.86%-2.73M4.44%-3.58M5.81%-2.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 40.20%-2.15M5.70%-10.83M30.61%-1.9M22.26%-2.78M-0.71%-2.55M-36.34%-3.6M13.60%-11.48M20.86%-2.73M4.44%-3.58M5.81%-2.53M
Basic earnings per share 85.08%-0.4748.51%-5.292.92%-0.1763.69%-1.1433.78%-1.47-34.62%-3.1518.71%-10.121.70%-2.46.55%-3.147.50%-2.22
Diluted earnings per share 85.08%-0.4748.51%-5.292.92%-0.1763.69%-1.1433.78%-1.47-34.62%-3.1518.71%-10.121.70%-2.46.55%-3.147.50%-2.22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg